Sanofi On Pace for Largest Percent Decrease Since October 2023 — Data Talk
Sanofi Sponsored ADR (SNY) is currently at $48.57, down $1.54 or 3.07%
--On pace for largest percent decrease since Oct. 27, 2023, when it fell 19.13%
--Snaps a three day winning streak
--Down 0.94% month-to-date; on pace for worst month since Feb. 2024, when it fell 4.11%
--Down 2.33% year-to-date
--Down 15.47% from its all-time closing high of $57.46 on April 11, 2022
--Down 9.62% from 52 weeks ago (June 28, 2023), when it closed at $53.74
--Down 12.01% from its 52-week closing high of $55.20 on Sept. 20, 2023
--Up 12.61% from its 52-week closing low of $43.13 on Oct. 27, 2023
--Traded as low as $48.19
--Down 3.83% at today's intraday low; largest intraday percent decrease since May 9, 2024, when it fell as much as 3.99%
All data as of 10:19:59 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
June 26, 2024 10:37 ET (14:37 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Q3 2024 Stock Market Outlook: Is the AI Stock Trade Over?
-
Ian Bremmer: 4 Big Geopolitical Risks to Watch
-
What’s Happening In the Markets This Week
-
Obesity Drug Stocks: Why It Will Be ‘Exceptionally Difficult’ to Dethrone Eli Lilly and Novo Nordisk
-
What Does Chipotle’s Stock Split Mean for Investors?
-
5 Stocks to Buy Before the Fed Cuts Interest Rates in 2024
-
Markets Brief: Inflation Is Back In the Spotlight
-
What a Strong Economy Now Means for the Rest of 2024
-
10 Top Dividend Stocks for 2024
-
Finding Small-Cap Stock Opportunities In a Big-Cap World
-
The 10 Best Companies to Invest in Now
-
Nike Earnings: Dim Sales Outlook Slams Shares, but Patient Investors Could Be Rewarded
-
2 Top E-Commerce Stock Picks
-
Our Top Pick for Investing in US Renewable Energy
-
Micron Earnings: We Raise Our DRAM Forecast and Valuation Behind Stronger Pricing Assumptions
-
10 Undervalued Wide-Moat Stocks